Medication info
Glorabe Tablet 10mg (Rabeprazole Sodium)

Glorabe Tablet 10mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Kips Bio Pharma Co., Ltd.
Appearance
Pale yellow round enteric-coated film-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201206679 · Approved 2012.09.03 · Insurance code 693200790

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use with antibiotics), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult oral dose is 10 mg of rabeprazole sodium once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medication 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medication for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution because hepatic function is often reduced.
Child dose
○ Pediatric patients Safety in pediatric patients has not been established.

Ingredients

Manufacturer
Kips Bio Pharma Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use with antibiotics), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers infected with Helicobacter pylori
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers, and is used to relieve symptoms of erosive or ulcerative gastroesophageal reflux disease and for long-term maintenance therapy. Additionally, it enhances therapeutic effects when combined with antibiotics in patients with gastrointestinal ulcers infected with Helicobacter pylori. It also aids in the treatment of Zollinger-Ellison syndrome. This drug suppresses gastric acid secretion, improving symptoms of ulcers and gastroesophageal reflux disease.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult oral dose is 10 mg of rabeprazole sodium once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medication 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medication for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Administer with caution because hepatic function is often reduced.

Child dose

○ Pediatric patients Safety in pediatric patients has not been established.

Precautions

This medication should not be used in individuals with a known allergy to this medication or its components or who have had hypersensitivity reactions to benzimidazoles. Caution is also needed for those with hypersensitivity reactions to penicillin antibiotics or macrolide antibiotics. Patients taking specific medications such as terfenadine, cisapride, pimodizole, astemizole or atazanavir, rilpivirine should not use this medication concurrently. It is safer not to use this medication during pregnancy or breastfeeding. Patients with impaired liver function, elderly individuals, and those with a history of drug allergies should use this medication cautiously. If allergic symptoms such as rash, hives, or itching occur while taking this medication, it should be discontinued immediately. Regular blood tests and liver function tests are recommended, and if abnormal signs are observed, medication use should be halted and a doctor consulted. Various side effects may occur in different body parts including the heart, gastrointestinal tract, nervous system, respiratory system, muscles, skin, eyes, and urinary system, so care should be taken if abnormal symptoms appear. Long-term use may increase the risk of osteoporosis and fractures, so appropriate measures should be discussed with a doctor as needed. This medication inhibits gastric acid secretion, which may slightly increase the risk of gastrointestinal bacterial infections; if diarrhea persists, medical personnel should be informed. Caution is needed when driving or operating machinery as drowsiness may occur. There may be interactions with other medications, so particularly when taking warfarin, methotrexate, antibiotics, antiviral agents, etc., it is essential to inform a doctor or pharmacist. This medication should be swallowed whole and not chewed or crushed, and it should be kept out of the reach of children. It is advisable not to use this medication during pregnancy or breastfeeding, and elderly individuals should use it cautiously due to potential liver function decline. Safety in pediatrics has not been established, so it is preferable not to use it. In case of overdose, as there is no specific antidote, appropriate treatment based on symptoms should be administered, and regular check-ups are necessary.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disorder, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neurogenic hypersensitivity, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory tinnitus, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, drowsiness, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, lumbago, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuritis, myotonia, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, polyuria, dysmenorrhea, urinary difficulty, nephrolithiasis, uterine bleeding, polydipsia, gynecomastia, elevated total cholesterol, elevated triglycerides, increased BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, malaise, weight gain, visual disturbances, appetite loss, neck stiffness, photosensitivity reactions, hangover effects, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow round enteric-coated film-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.